American pharmaceutical company AbbVie has marked its entry into the Indian cancer drugs segment with Venetoclax used to ...

Through the launch of Venetoclax for the treatment of both Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL ...

Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.

US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...

Fugitive businessman Mehul Choksi battles chronic lymphocytic leukemia while facing extradition from Belgium Learn all about ...

acute monoblastic leukemia and acute nonlymphocytic leukemia. In Chronic Myeloid Leukemia (CML), too many blood stem cells develop into an abnormal type of white blood cell. Called granulocytes, these ...

We previously presented the phase 1b trial data, which showed that patients with acute leukemia and MDS who received ... were free of moderate to severe chronic graft-vs-host disease and alive ...

Master Trial is at the heart of LLS's Dare to Dream Project to transform treatment and care for kids with blood cancer WASHINGTON, April 21, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) ...

Anthony S. Stein, MD, discusses a study of total marrow and lymphoid irradiation 20 Gy and post-transplant cyclophosphamide in acute myeloid leukemia undergoing allogeneic hematopoietic cell ...

Adding venetoclax to decitabine-cedazuridine significantly enhanced response rates in patients with higher-risk ...